A better alternative for joint disease
OSTEOARTHRITIS (OA), the most common joint disease, was long viewed to result from age-related wear and tear.
Rheumatoid arthritis (RA), on the other hand, results from an auto immune attack on the joints.
In 2011, Stamford University discovered the auto immune link between OA and RA.(1)
They concluded that the development of OA triggers the auto immune system to attack the joint lining and cartilage as it mistook the exposed collagen in the cartilage as a foreign invasive body.
What was needed was to retrain the immune system to treat exposed collagen as a harmless substance.
The study revealed that by targeting this auto immune derangement that occurs early in the development of OA, arthritis might be completely preventable. This new finding coincided with the development of a natural intervention shown to protect tissues in ageing joints called undenatured type II collagen.
This revolutionary and side-effect free form of undenatured type II collagen process from chicken sternum called UC II has been shown to desensitise the immune system and prevent pro-inflammatory auto immune attacks on ageing joints.
Clinical studies from Harvard University on the effect of UC II Flaxical on patients with RA showed a significant decrease in the number of swollen and painful joints. 14% of patients achieved complete remission and no side effect was found.(2)
The 90-day trial found significant enhancement in daily activity suggesting an improvement in the quality of life. It compared the result of using 40mg of UC II Flaxical a day against a combination of 1,500mg a day of glucosamine plus 1,200mg a day of chondroitin sulphate.
The result was that UC II was more than twice as effective in terms of reducing arthritic symptom.(3)
What is Flaxical 3 in 1?
Flaxical is the only supplement in the market using three patented whole food ingredient for joints, bones and inflammation.
Bone is an integral component of joints, affecting overall joint function.
Calcium is essential in building and maintaining healthy bone, thereby preventing bone fractures associated with osteoporosis.
Flaxical triple action uses patented whole food calcium and magnesium from seaweed directly imported from Ireland.
Promoting long-term joint health
Flaxical Patented undenatured type II collagen (UC II) has been shown in numerous studies and clinical trials to help the body repair and rebuild joint cartilage and prevent auto immune attack on ageing joints, promoting long-term joint health.
While undenatured type II collagen is effective in reducing joint pain and inflammation, Flaxical further enhances this by adding ginger extract and ginger juice powder into its formulation.
Ginger has been used by Indian healers to reduce joint pain and inflammation. Recent studies have backed this up. Consumers taking supplements for their joint problem and also taking calcium and magnesium supplements will enjoy substantial savings when they switch over to Flaxical 3 in 1.
Not only will they enjoy cost savings but also a more effective solution for their joint problem with superior quality patented whole food calcium and magnesium.
KJI Pharmaco believes that for supplements, the integrity of the ingredients is of utmost importance. Only premium and or patented ingredients are used and at clinical dosage to maximise the efficacy.
Flaxical 3 in 1 is available in selected pharmacies. Enjoy the promotional twin packs with complimentary hot and cold flask or single pack at RM149 (inclusive of GST).
For details, call 03-7772 7133 or 012-238 0133 (Monday to Friday, 9am to 6pm).
References
Wang Q, Rozelle AL, Lepus CM, et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011 Nov 6.
Trentham DE, Dynesius – Trentham RA Orav EJ. et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993 Sept 24: 261(5129)1727–30.
Crowley DC, Lau FC, Sharma P. et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci.2009;6(6)312-21.